Genetic Testing for Familial Hyperinsulinism (FHI), ABCC8-Related

Familial hyperinsulinism causes a baby's pancreas to release too much insulin, which can lead to dangerously low blood sugar. For people of Ashkenazi Jewish descent, the odds of carrying the ABCC8 gene change behind this inherited condition are higher than in the general population. Carriers have no symptoms themselves, so many families don't learn they're at risk until they have an affected child. A carrier screen for familial hyperinsulinism, ABCC8-related, checks for this gene change so you can understand your risk before you're expecting or planning a pregnancy.

What Is Familial Hyperinsulinism?

Familial hyperinsulinism happens when the pancreas releases too much insulin, the hormone that pulls sugar out of the bloodstream and into the body's cells. With too much insulin circulating, blood sugar drops far lower than it should, and a newborn doesn't get the steady fuel supply their body needs to survive.1,2

In newborns, the signs of FHI can be easy to miss and can include: poor feeding, low muscle tone, breathing pauses, or seizures brought on by a sudden drop in blood sugar. Some children aren't diagnosed until later in infancy or childhood.1

Treatment usually starts with diazoxide, currently the only medicine approved specifically for FHI, along with a careful feeding schedule to help keep blood sugar steady.1 For the smaller number of children whose blood sugar can't be controlled with medication alone, surgery to remove part of the pancreas may be considered.1 For children who can be managed medically, glucose control usually gets easier over time, and many enter clinical remission after months or years of treatment.1

ABCC8

ABCC8 is a gene that gives instructions for building part of a channel in the pancreas that helps control when insulin is released.2 When a change in the ABCC8 gene stops the channel from working as it should, the pancreas releases insulin even when the body doesn’t need it, causing low blood sugar.1,2‍

If both parents are carriers, each pregnancy has:1,3

  • A 25% chance the child inherits a nonworking copy from each parent and is affected
  • A 50% chance the child is an unaffected carrier, like the parents
  • A 25% chance the child inherits two working copies and is unaffected

The classic inheritance pattern, called autosomal recessive inheritance, happens when a child inherits one nonworking copy of ABCC8 from each parent. A carrier has one working copy and one nonworking copy, and carriers have no symptoms at all because the one working copy is enough.1,3

There's an important exception worth knowing about. Even when only the father carries a change in ABCC8 and the mother isn't a carrier, a child can occasionally still develop a form of the condition called focal hyperinsulinism. This happens when a separate, non-inherited change occurs in a small patch of pancreas cells early in development, on top of the copy already inherited from the father. This second event is random, so the overall chance is low, about 1 in 540 for the child of a father who carries a change in ABCC8. Still, it's real enough that the father's carrier status matters on its own.1

Why Carrier Screening Matters

Carriers show no signs of the condition, and family history alone can't always predict which children will be affected, especially with the focal form. Since there's no way to tell who carries a change in ABCC8 just by looking at a family tree, carrier screening is the most reliable way to understand your risk before a pregnancy begins, rather than after a child is already affected.

Your Odds of Carrying the ABCC8 Gene Change

Familial hyperinsulinism is one of several conditions linked to Ashkenazi Jewish ancestry, and the numbers are meaningful. A specific change in ABCC8, known as c.3989-9G>A, is estimated to affect about 1 in 83 people of Ashkenazi Jewish descent.1 Familial hyperinsulinism is much rarer in the general population, affecting an estimated 1 in 50,000 births overall, which is part of why ancestry-based screening carries so much weight.5

Who Should Consider Screening

A few groups in particular should make familial hyperinsulinism screening a priority:
1.

Ashkenazi Jewish Ancestry

A specific ABCC8 change is estimated to affect about 1 in 83 people of Ashkenazi Jewish descent, a carrier rate high enough on its own to make screening worth prioritizing.

2.

A Father Who Carries the ABCC8 Gene Change

Focal hyperinsulinism can develop even when only the father passes down a change in ABCC8 and the mother isn't a carrier at all, so a father's carrier status matters on its own.

3.

Planning a Pregnancy

Screening before you conceive means you'll have your carrier results in hand while you still have the most options.

4.

A Partner Who Has Already Screened Positive

If your partner is a known carrier for FHI, screening tells you whether your child's risk comes from the classic inherited form, the rarer focal form, or neither.

5.

Using a Sperm or Egg Donor

A donor's genetic background carries the same considerations a partner's would, so screening applies just the same.

6.

Familial Hyperinsulinism in Your Immediate Family

A family history of the condition, including a relative with unexplained, severe low blood sugar as a newborn, raises the chance that a change in ABCC8 is already running in the family.

How At-Home Genetic Testing Works

Order and register

Order your at-home genetic test and register online.

Collect your sample

Your sample collection kit should arrive 7–10 business days after registration.

Return your sample

Follow the instructions in the kit to collect and return your sample.

Get your results

Results are typically available 2-3 weeks after the sample reaches the lab.

Talk to a genetic counselor

You’ll have the opportunity to discuss your results with a genetic counselor.

Costs and Insurance Coverage

jscreen is committed to making carrier screening financially accessible, regardless of your insurance status.

Insurance Billing

Most commercial insurance plans cover carrier testing for individuals and couples planning to start or expand their family. Insurance plans also often cover carrier testing for individuals with Ashkenazi Jewish heritage. Your final cost depends on your family history and specific insurance plan. Our care navigators are here to help you work through the process and connect you with our financial assistance programs as needed. 1

Self-Pay Option

Prefer not to use insurance? jscreen offers a straightforward, competitive self-pay rate of $249, plus the upfront fee of $49, for a total of $298. This covers lab testing fees, physician review and test ordering, and access to our genetic counselors and care navigators throughout the testing process. 1

Understanding Your Results

Every test from jscreen is reviewed by board certified genetic counselors, and results generally fall into one of two categories.

Positive (Carrier)

What this means:

A positive result means you carry one working copy and one nonworking copy of ABCC8.1,3 You are not affected by familial hyperinsulinism and never will be, but you can pass the nonworking copy to a child. If you're planning a pregnancy, this is the point where your partner should also be screened, since your child's risk depends on whether your partner carries a change in the same gene.

Negative Result

What this means:

A negative result means you have a significantly lower chance of being a carrier for familial hyperinsulinism. It lowers your risk significantly without bringing it all the way to zero.

If You and Your Partner Are Both Carriers

What this means:

If both partners carry a change in ABCC8, each pregnancy has a 25% chance of being affected by familial hyperinsulinism.1,3 If you are already pregnant, diagnostic tests such as chorionic villus sampling or amniocentesis can determine whether a current pregnancy is affected, giving you an answer before birth.4 Genetic counseling is strongly recommended, and every jscreen result comes with access to a board certified genetic counselor to walk through what your specific results mean.

Know Your Risk Before You're Expecting

Familial hyperinsulinism can't always be predicted by family history alone, but knowing your carrier status early gives you the most information and the most options. Carrier screening puts that knowledge in your hands before you're pregnant, not after. Take a proactive step toward protecting your future family.

Frequently Asked Questions

Is There a Genetic Test for Familial Hyperinsulinism?

Yes. Testing can be done before or during pregnancy. Carrier screening checks whether you or your partner carry a variant in ABCC8, the gene linked to this form of Familial Hyperinsulinism (also called congenital hyperinsulinism). If you’re already pregnant, prenatal diagnostic testing can determine whether the baby is affected.

What Does an ABCC8-Related Hyperinsulinism Test Show?

Your results will generally fall into one of two categories:

Negative: You’re unlikely to be a carrier, though no test can rule out every possible variant.

Positive: You carry one working copy and one non-working copy of ABCC8. Carriers usually have no symptoms themselves. If your partner is also a carrier, each pregnancy has a 25% chance of the child having Congenital Hyperinsulinism. If you are the father and your partner is not a carrier, there’s still a small chance (about 1 in 540) of a child developing the focal form.

‍

Is There a Familial Hyperinsulinism Prenatal Test?

If you're already pregnant and both partners are found to be carriers, diagnostic testing such as chorionic villus sampling or amniocentesis can determine whether the pregnancy is affected, rather than waiting until birth.4

How Do You Test for Familial Hyperinsulinism From Home?

A familial hyperinsulinism DNA test through jscreen happens entirely from home. You order a kit online, provide a saliva sample using the instructions included, and mail it back using the prepaid materials in the kit. Your sample is analyzed at a CLIA-accredited laboratory, and results are typically available within 3 to 4 weeks.

Why Is Familial Hyperinsulinism More Common Among Ashkenazi Jewish People?

A specific change in the ABCC8 gene became more common in the Ashkenazi Jewish population generations ago. Certain genetic diseases are more common within communities that were historically isolated – whether geographically, culturally, or religiously. When one or more ancestors in such a group carried a mutation in a disease-related gene, that mutation had the opportunity to spread and take root over generations. These types of genetic mutations are known as "founder mutations,” which is why about 1 in 83 people with Ashkenazi Jewish ancestry carry it today, compared to a much lower rate in the general population.1

What Happens if Only the Father Carries the ABCC8 Gene Mutation?

Yes, though it’s uncommon. When only the father carries an ABCC8 variant, his child has about a 1 in 540 chance per pregnancy of developing focal congenital hyperinsulinism.¹

Most hereditary genetic disorders like congenital hyperinsulinism follow a recessive pattern, meaning a child needs a variant from both parents. The focal form works differently. The child inherits the father’s ABCC8 variant, and then, during early development, a small patch of pancreas cells loses the working copy from the mother. Those cells are left with only the father’s changed copy, which causes them to release too much insulin.

That’s one reason genetic counselors consider a father’s carrier status meaningful on its own. And if both parents carry an ABCC8 variant, the chance of a child having the more common diffuse form of hyperinsulinism rises to 1 in 4. Genetic testing for hereditary diseases before or during pregnancy can help you and your partner understand both risks.¹

Do I Need Genetic Counseling After My Results?

We highly encourage everyone to schedule a genetic counseling session, regardless of your test results. Screening through jscreen includes a no-cost consultation with a board-certified genetic counselor who can explain your specific results and your options going forward.

What Happens if My Partner and I Are Both Carriers?

When both parents are carriers, each pregnancy has:

  • A 25% chance of the child being affected
  • A 50% chance of the child being an unaffected carrier
  • A 25% chance of the child inheriting two working copies¹

Working with a genetic counselor will help a carrier couple talk through their options, which can include prenatal diagnostic testing during a current pregnancy, in vitro fertilization with preimplantation genetic testing before conceiving, or other family planning approaches.

References

‍

  1. Gillis D. Nonsyndromic Genetic Hyperinsulinism Overview. GeneReviews. University of Washington, Seattle. Initial posting August 19, 2003. Updated October 31, 2024. Accessed September 11, 2026. https://www.ncbi.nlm.nih.gov/books/NBK1375/‍
  2. ABCC8 Gene. MedlinePlus Genetics. National Library of Medicine. Last updated January 13, 2026. Accessed September 11, 2026.
    https://medlineplus.gov/genetics/gene/abcc8/
  3. ABCC8-Related Conditions. Norton & Elaine Sarnoff Center for Jewish Genetics. Last updated October 9, 2023. Accessed September 11, 2026. https://www.jewishgenetics.org/genetic-disorders/search-genetic-disorders/abcc8-related-conditions/
  4. Chorionic Villus Sampling (CVS). Cleveland Clinic. Last reviewed August 8, 2024. Accessed September 11, 2026. https://my.clevelandclinic.org/health/diagnostics/4028-chorionic-villus-sampling-for-prenatal-diagnosis
  5. Congenital Hyperinsulinism (HI) Panel Testing Information. Genetic Diagnostic Laboratory, Department of Genetics, University of Pennsylvania School of Medicine. June 26, 2025. Accessed September 11, 2026. https://genetics.med.upenn.edu/assets/user-content/documents/hi-panel-with-hk1-info-sheet-2025.pdf